2024. Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical Trials. Journal of Kidney Cancer. 11, 3 (Aug. 2024), 51–58. DOI:https://doi.org/10.15586/jkcvhl.v11i3.352.